Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido
2000
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family.
September 2016, Journal of medicinal chemistry,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
September 1995, Journal of medicinal chemistry,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Epidermal growth factor receptor tyrosine kinase inhibitors.
June 2004, British journal of cancer,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Epidermal growth factor receptor tyrosine kinase inhibitors.
August 2002, Current opinion in pharmacology,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
April 2007, Cancer letters,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
August 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor.
February 2001, Journal of medicinal chemistry,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Epidermal growth factor receptor first generation tyrosine-kinase inhibitors.
November 2019, Translational lung cancer research,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors.
January 2003, The oncologist,
Smaill, and Rewcastle, and Loo, and Greis, and Chan, and Reyner, and Lipka, and Showalter, and Vincent, and Elliott, and Denny
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
November 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name